Manager, Portfolio Management

U023 (FCRS = US023) Sandoz Inc; Princeton (NJ); Hybrid; USD 119,000 - 220,000; Full time

Benefits offered by this job

Hybrid work policy

Competitive compensation

Job summary

Sandoz Inc is seeking a Manager of Portfolio Management (Execution Focus) in Princeton, NJ, to turn portfolio guidance into decision-ready outputs. This hybrid role emphasizes governance readiness, forecast integrity, and AI-enabled efficiency.

The position reports to the Senior Director, Portfolio Management and requires 3+ years in pharma/biotech with generics exposure. The role focuses on driving execution readiness, risk identification, and cross-functional collaboration across R&D,

Qualifications

• Education: Bachelor’s degree in Pharmacy, Life Sciences, Business, Engineering, or Finance is required.
• Experience: 3+ years in pharma/biotech with exposure to generics; portfolio or execution roles preferred.
• Travel Requirements: Up to 5%.

Responsibilities

• Prepare governance-ready materials for portfolio forums with clear framing and validated data.
• Maintain portfolio forecasts and scenarios across internal and BD assets; summarize changes and implications.
• Coordinate inputs across R&D, Regulatory, Commercial, Finance, Supply, and BD teams to resolve data gaps early.
• Build and improve templates, dashboards, automation, and AI-enabled workflows to reduce manual effort and cycle time.
• Manage portfolio timelines, data refreshes, and deliverables to ensure readiness before decision points.
• Track decisions, actions, owners, and timelines; ensure updates are reflected in materials and forecasts.

Skills

Execution discipline

Cross-functional collaboration

Data analytics

AI-enabled workflows

Education

Bachelor’s degree in Pharmacy, Life Sciences, Business, Engineering, or Finance

Tools

Copilot AI

Job description

Job Description Summary

The Manager of Portfolio Management (Execution Focus) enables day-to-day portfolio execution by turning portfolio priorities, guidance, and governance decisions into accurate, decision-ready outputs. Reporting to the Senior Director, Portfolio Management, this role works closely with director-level portfolio leads across both in-house and Business Development portfolios and acts as the execution backbone of the portfolio function. The role is accountable for execution readiness, follow‑through, and efficiency—driving material productivity gains by replacing manual work with scalable, AI‑enabled processes (for example, using the Copilot interface and capabilities). The role is expected to proactively identify risks, data gaps, and decision blind spots, and to flag options to portfolio leadership. This is an individual contributor role with no direct people management responsibilities.

Position Location:

This position will be located at the Princeton, NJ US Headquarters site. Our Sandoz flexible hybrid working approach allows US office‑based employees to work up to 50% of their monthly workday remotely. This role will not have the ability to be located remotely. Must be authorized to work in the U.S. U.S. work visa sponsorship is not available for this role now or in the future.

Major Accountabilities / Your Key Responsibilities:

• Portfolio Governance & Execution Readiness (Enable Timely Decisions): Prepare governance‑ready materials for portfolio forums by building slides, validating data, and ensuring clear decision framing. Deliver complete, accurate materials on time with minimal rework.
• Portfolio Forecasting & Change Control Support (Maintain Integrity): Maintain portfolio forecasts and scenarios across internal and BD assets by updating our internal pipeline system. Clearly summarize changes and implications to support timely governance decisions.
• Business Development Portfolio Enablement (Support Inorganic Execution): Support BD‑led assets by coordinating inputs, maintaining trackers, and reflecting deal and development changes in portfolio forecasts and materials as opportunities progress.
• Process, Tools & AI Enablement (Deliver Step-Change Efficiency): Build and improve templates, dashboards, automation, and AI‑enabled workflows on product evaluations that reduce manual effort, rework, and cycle time. Convert repetitive work into scalable, low‑touch processes.
• Operating Rhythm Management (Keep the Portfolio Running): Manage portfolio timelines, data refreshes, and deliverables across the internal pipeline, BD funnel, and governance activities to ensure readiness ahead of decision points.
• Cross-Functional Coordination (Get Work Done in a Matrix): Coordinate inputs across R&D, Regulatory, Commercial, Finance, Supply, and BD teams. Resolve data gaps or inconsistencies early to prevent downstream delays.
• Execution Accountability & Follow-Through (Close the Loop): Track decisions, actions, owners, and timelines from portfolio forums and ensure updates are reflected consistently in materials, forecasts, and next steps.
• Special Projects & Priority Analyses (Deliver on Demand): Execute priority analyses or execution‑focused portfolio initiatives as assigned, delivering clear, practical outputs with minimal oversight.
• Risk Identification and Escalation (Protect Decision Quality): Proactively surface timeline, data integrity, or cross‑functional execution risks that could compromise portfolio readiness or decision quality.

Key Performance Indicators:

• Governance Readiness & Quality: Delivers complete, accurate, decision‑ready materials for portfolio governance forums, with clear framing, validated data, and zero rework.
• Forecast Integrity & Responsiveness: Maintains high‑confidence, up‑to‑date portfolio forecasts that respond rapidly to new information, scenario changes, and leadership requests.
• Execution Predictability: Ensures portfolio deliverables, analyses, and timelines are reliably met, reducing surprises and execution variability.
• Process & Tool Impact: Improves portfolio execution outcomes through standardized processes, fit‑for‑purpose tools, and measurable productivity gains.
• AI‑Driven Efficiency Gains: Replaces manual, repetitive work with AI‑enabled workflows to materially reduce cycle time and analyst effort.
• Leadership Support: Extends Director and Executive Director effectiveness by ensuring execution readiness, proactive issue surfacing, and seamless follow‑through on decisions.

Key Capabilities Required:

• Execution-First Orientation: Relentlessly focused on execution excellence—turning direction into accurate, on‑time outputs, not owning portfolio strategy or final investment decisions.
• Project & Portfolio Discipline: Manages multiple priorities with rigor, structure, and strong follow‑through across complex, cross‑functional portfolios.
• Data, Analytics & AI Fluency (Copilot, Salesforce.com, Power BI): Uses data, dashboards, and AI tools to drive insights, automate workflows, and improve decision speed and quality.
• Executive-Ready Communication: Produces clear, concise, and decision‑oriented materials suitable for senior leadership without rework or translation.
• Cross-Functional Collaboration: Works seamlessly across R&D, BD, Regulatory, Supply Chain, Finance, and Commercial to ensure aligned and timely portfolio execution.

Job Dimensions:

Impact on the organization: Medium. This role materially improves execution quality, forecast reliability, governance efficiency, and operating leverage across the generic portfolio—enabling portfolio leadership to scale.

What you’ll bring to the role:

Required Qualifications:

• Education: Bachelor’s degree in Pharmacy, Life Sciences, Business, Engineering, or Finance is required.
• Experience: 3+ years in pharma/biotech with exposure to generics; portfolio or execution roles preferred.
• Travel Requirements: Up to 5% Ability to work independently from home or office when necessary for business purposes.

You’ll Receive:

• Sandoz offers a generous employee benefits package that includes a competitive salary, health insurance coverage for medical, prescription drugs, dental and vision, a generous company match for retirement savings accounts, and generous paid time off.
• We also follow a hybrid work policy that combines a mix of in-person and remote work to allow our employees flexibility.
• The pay range for this position at commencement of employment is expected to be between $118,500 - 220,100SD/year; however, while salary ranges are effective from 1/1/26 through 12/31/26, fluctuations in the job market may necessitate adjustments to pay ranges during this period. Further, final pay determinations will depend on various factors, including, but not limited to geographical location, experience level, knowledge, skills and abilities.
• The total compensation package for this position may also include other elements, including a sign‑on bonus, restricted stock units, and discretionary awards in addition to a full range of medical, financial, and/or other benefits (including 401(k) eligibility and various paid time off benefits, such as vacation, sick time, and parental leave), dependent on the position offered.
• Details of participation in these benefit plans will be provided if an employee receives an offer of employment.
• If hired, employee will be in an “at‑will position” and the Company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time, including for reasons related to individual performance, Company or individual department/team performance, and market factors.

On September 30, 2021, Sandoz entered into a 5-year Corporate Integrity Agreement. Certain positions will have responsibilities to support the execution and adherence to CIA obligations, CIA‑related deliverables, and any relevant audit, monitoring or Independent Review Organization (IRO) remediation. Sandoz ‑ Notice at Collection to Employees Applicants 4.15.24[16].pdf

Why Sandoz? Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, provided more than 900 million patient treatments across 100+ countries in 2024 and while we are proud of this achievement, we have an ambition to do more! With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help more patients gain access to low‑cost, high-quality medicines, sustainably. Our momentum is powered by an open, collaborative culture driven by our talented and ambitious colleagues, who, in return for applying their skills experience an agile and collegiate environment with impactful, flexible‑hybrid careers, where diversity is welcomed and where personal growth is supported! Join us!

EEO Statement: All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or protected veteran status.

Accessibility and reasonable accommodations Sandoz, Inc. is committed to working with and providing reasonable accommodation to individuals with disabilities. If, because of a medical condition or disability, you need a reasonable accommodation for any part of the application process, or in order to perform the essential functions of a position, please send an email to [e-mail] or call 1-609-422-4098 and let us know the nature of your request and your contact information. Please include the job requisition number in your message.

Our Purpose here at Sandoz is pioneering access for patients. As the global leader in 'off-patent' high quality medicines, we are able to make medicine more affordable and accessible. Our broad global portfolio comprises of approximately 1,300 quality biosimilar and generic medicines, enabling us to provide more than 900 million patient treatments across 100+ countries per year, and while we are proud of this achievement, we have an ambition to do more! Powered by our talented and ambitious colleagues, who, in return for dedication and skills, experience a flexible, collaborative & inclusive culture where diversity of thought is welcomed and where personal growth is nurtured!